Tag Archives: GIGM

investment consultant

While Light-emitting diodes or LEDs have many advantages over traditional incandescent light sources,LED stocks have not necessarily been big winners for investors or traders alike. However, there are some signs that could be starting to change.

Beginning with small cap Cree, Inc (NASDAQ: CREE), the Company is aleading innovator of lighting-class LEDs, lighting products and wide bandgap semiconductor products for power and radio frequency (RF) applications. Cree, Inc’s product families include LED lighting systems and bulbs, blue and green LED chips, high-brightness LEDs, lighting-class power LEDs, SiC materials, power devices and RF devices that are used in applications such as commercial and consumer general illumination, video screens, electronic signs and signals, motor drives, power supplies, EV charging, solar, traction, transportation, radar, communications, telecom, data link and broadband amplifiers.

investment consultant: Shopify Inc.(SHOP)

Advisors’ Opinion:

  • [By WWW.FOOL.COM]

    Shopify(NYSE:SHOP)stock has been on a tear, rocketing up over 180% since the company went public in May of 2015. The company’s business model is pretty simple: Sign up merchants, charge merchants to use its platform, help merchants sell stuff, and take a small percentage from each sale. Then, rinse and repeat at alarger scale with more profitability. Shopify is executing this strategy extremely well, posting strong third quarter 2016 results with record growth in total merchants, sales volume, and revenue.

  • [By Adam Levy]

    Shopify’s(NYSE:SHOP) fourth-quarter earnings results came in above expectations, continuing its flawless streak of earnings beats since going public. The company posted revenue of $130.4 million and breakeven earnings per share. Analysts were expecting a $0.02 loss per share on $121.7 million in sales.

  • [By Dan Caplinger, Tim Brugger, and Seth McNew]

    Risk is always a factor for stock market investors, but if you want the top stocks in your portfolio, you have to be bold. To give you some ideas on which stocks to look at, three Motley Fool contributors weighed in on companies they’re familiar with and made a case for why they deserve a closer look. Read on to learn more about Shopify (NYSE:SHOP), Chipotle Mexican Grill (NYSE:CMG), and Universal Display (NASDAQ:OLED) and why they deserve your attention.

  • [By ]

    Shopify (NYSE: SHOP) is an ecommerce platform and hosting company providing the websites and tools for small businesses. The company and its customers might not have the financial capital for access to fast lanes in a post-neutral internet.

  • [By WWW.MONEYSHOW.COM]

    Shopify (SHOP) is especially designed for small and medium-sized businesses. It is based in Ottawa, Canada.

    I like this stock recommendation because this is a young company that focuses on providing on-line marketing solutions at a reasonable price for small and mid-size companies.

investment consultant: Express Scripts Holding Company(ESRX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

    Analysts are expecting Discovery Communications Inc. (NASDAQ: DISCA) to have earned $0.47 per share on revenue of $1.69 billion in the latest quarter. Discovery Communications shares rose 0.17 percent to $29.08 in after-hours trading.
    Analysts expect T-Mobile US Inc (NASDAQ: TMUS) to report

  • [By ]

    Express Scripts Holding (Nasdaq: ESRX) has already stated publicly that it would be open to an acquisition. The company is the largest PBM in the United States, with more than 1.4 billion adjusted claims processed annually as well as a strong home delivery pharmaceuticals service.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Tuesday was Express Scripts Holding Co. (NASDAQ: ESRX) which traded down 11% at $59.98. The stocks 52-week range is $57.80 to $80.02. Volume was 35.4 million versus the daily average of 4.4 million shares.

investment consultant: Zions Bancorporation(ZION)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    In the super-regional banks that are not money center banks, Regions Financial Corp. (NYSE: RF) was up 6.3% at $13.22, and Zions Bancorporation (NASDAQ: ZION) was last seen up 3.8% at $38.30. They would both do better with lower regulatory costs and be able to better compete against larger banks when their stress test results had not been as strong.

  • [By Nelson Hem]

    See what Barron's feels the prospects are for Energy Transfer Partners LP (NYSE: ETP) if it cuts its distribution and dumps its general partner, and salesforce.com, inc. (NYSE: CRM) with its generous potential upside. Also whether regional banks like Zions Bancorp (NASDAQ: ZION) could see a boost from a proposed regulatory change, and the sweetheart deal the Koch brothers got with Meredith Corporation (NYSE: MDP).

investment consultant: GigaMedia Limited(GIGM)

Advisors’ Opinion:

  • [By Jim Robertson]

    Today, our Under the Radar Moversnewsletter suggested small cap online gaming and cloud computing GigaMedia Limited (NASDAQ: GIGM) as a bullish long trade:

investment consultant: Spark Networks, Inc.(LOV)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap dating site stock Match Group Inc (NASDAQ: MTCH), which was spun off from media and Internet stock IAC/InterActiveCorp (NASDAQ: IAC) and is a peer or remaining dating stock Spark Networks Inc (NYSEMKT: LOV), is the eight most shorted stock on theNASDAQ with short interest of 43.96% according to Highshortnterest.com.

Top 10 Medical Stocks To Invest In 2018

Marijuana is well on its way to becoming the “norm” in modern America.

Eight states – Alaska, California, Colorado, Maine, Maryland, Massachusetts, Oregon, and Washington – and the District of Columbia have fully legalized possession of small amounts of marijuana for adults’ recreational use. An additional 13 states have decriminalized it. And 29 states, along with Puerto Rico and Guam, now allow the use of medical marijuana.

However, the drug is still classified as an illegal Schedule I substance in the eyes of the federal government.

Top 10 Medical Stocks To Invest In 2018: CareDx, Inc.(CDNA)

Advisors’ Opinion:

  • [By Lisa Levin]

    CareDx Inc (NASDAQ: CDNA) was down, falling around 25 percent to $1.61 after the company reported weak preliminary sales for fourth quarter and FY 2016.

Top 10 Medical Stocks To Invest In 2018: CRH Medical Corporation(CRHM)

Advisors’ Opinion:

  • [By Lisa Levin]

    CRH Medical Corp (NYSE: CRHM) was down, falling around 31 percent to $2.55 after the company disclosed financial and operating results for the quarter and six months ended June 30, 2017.

Top 10 Medical Stocks To Invest In 2018: Enphase Energy, Inc.(ENPH)

Advisors’ Opinion:

  • [By Ben Levisohn]

    UPDATE: I stand corrected. There does appear to be a reason for First Solar’s market-leading move today. Axiom Capital’s Gordon Johnson attributes the rise to the $10 million investment in Enphase Energy (ENPH), which makes “microinverter systems for the solar photovoltaic industry,” by investors T.J. Rodgers and John Doerr.

Top 10 Medical Stocks To Invest In 2018: Ideal Power Inc.(IPWR)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Thursday, our Under the Radar Moversnewslettersuggested smallcap electrical power conversion product stock Ideal Power Inc (NASDAQ: IPWR)as a long trade:

Top 10 Medical Stocks To Invest In 2018: GigaMedia Limited(GIGM)

Advisors’ Opinion:

  • [By Jim Robertson]

    Today, our Under the Radar Moversnewsletter suggested small cap online gaming and cloud computing GigaMedia Limited (NASDAQ: GIGM) as a bullish long trade:

Top 10 Medical Stocks To Invest In 2018: Neovasc Inc.(NVCN)

Advisors’ Opinion:

  • [By Lisa Levin] Related NVCN 18 Biggest Mid-Day Losers For Wednesday Legal Overhangs Keep Ladenburg Neutral On Neovasc Despite Positive Tiara Clinical Data Boston Scientific closes Neovasc transaction (Seeking Alpha)
    Related BSX Watch These 10 Huge Call Purchases In Monday Trade Wonderful Wearables Get Their Own ETF Boston Scientific closes Neovasc transaction (Seeking Alpha) Gainers
    Neovasc Inc (US) (NASDAQ: NVCN) rose 17.3 percent to $2.65 in pre-market trading after the company reported the close of its $75 million transaction with Boston Scientific Corporation (NYSE: BSX).
    aTyr Pharma Inc (NASDAQ: LIFE) shares rose 12.3 percent to $4.10 in pre-market trading after the company disclosed 'promising' signals in myopathies with Resolaris in exploratory trials.
    Globus Maritime Ltd (NASDAQ: GLBS) shares rose 10.1 percent to $6.90 in pre-market trading after climbing 5.03 percent on Monday.
    Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) shares rose 9.9 percent to $3.00 in pre-market trading. Aurinia Pharmaceuticals appointed Lorin Jeffry “Jeff” Randall to its board and Chairman of the Audit Committee.
    Ocean Rig UDW Inc. (NASDAQ: ORIG) shares rose 8.7 percent to $2.89 in pre-market trading after surging 19.82 percent on Monday.
    Full House Resorts, Inc. (NASDAQ: FLL) shares rose 5.1 percent to $2.08 in pre-market trading after declining 1.98 percent on Monday.
    Seadrill Ltd (NYSE: SDRL) rose 5.1 percent to $4.13 in pre-market trading after surging 3.15 percent on Monday.
    Noble Corporation (NYSE: NE) rose 5.1 percent to $7.60 in pre-market trading after declining 5.37 percent on Monday.
    Arbutus Biopharma Corp (NASDAQ: ABUS) rose 5.1 percent to $3.10 in pre-market trading. Arbutus issued additional data from its ARB-1467 Phase II
  • [By Lisa Levin]

    Neovasc Inc (US) (NASDAQ: NVCN) shares were also up, gaining 71 percent to $0.880 following announcement of an agreement with Boston Scientific Corporation (NYSE: BSX).

Top 10 Medical Stocks To Invest In 2018: Archer-Daniels-Midland Company(ADM)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Aflac (AFL) — yielding 2.5%
    Archer-Daniels Midland (ADM) — yielding 2.7%
    Chevron (CVX) — yielding 3.8%
    ExxonMobil (XOM) — yielding 3.6%
    Genuine Parts (GPC) — yielding 2.7%
    Johnson & Johnson (JNJ) — yielding 2.8%
    T. Rowe Price (TROW) — yielding 3.2%

Top 10 Medical Stocks To Invest In 2018: Barclays PLC(BCS)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    Barclays PLC (NYSE: BCS) was raised to Overweight from Equal Weight at Morgan Stanley. Its American depositary sharesclosed up 2.6% at $11.36 on Thursday and were indicated up 1.2% at $11.50 on Friday. The52-week range is $6.76 to $12.05.

  • [By WWW.THESTREET.COM]

    Banco Santander (SAN) : “I prefer Barclays (BCS) , but let’s wait and see what the other banks have to say”

    ProLogis (PLD) : “I am not a fan of that group right now, but that one is best of breed.”

Top 10 Medical Stocks To Invest In 2018: Exelon Corporation(EXC)

Advisors’ Opinion:

  • [By Horizon Investments]

    For the past year, Exelon Corp. (EXC) has had a roller coaster ride, with the stock having plummeted 15% since September 2012 – the company had announced a dividend cut of 41%, which led to a drop in the share price. Separately, the recent weak PJM auction prices did not bode well for the company. However, I believe the worst is priced in the stock price, and the company’s management is committed to improving its financial flexibility and cost structure in order to strengthen its financial performance. Also, the company is planning to incur capital expenditure (CAPEX) in the upcoming years, which will result in rate base growth for Exelon.

  • [By Casey Wilson]

    That brings us to General Electric Co. (NYSE: GE). The 125-year-old American mainstay signed a deal with Exelon Corp. (NYSE: EXC) last fall for the energy utility to use its own predictive analytics software, fittingly dubbed “Predix.”

  • [By Lisa Levin]

    Utilities shares climbed by 0.64 percent in trading on Friday. Meanwhile, top gainers in the sector included Exelon Corporation (NYSE: EXC), and FirstEnergy Corp. (NYSE: FE).

  • [By Monica Gerson]

    Analysts are expecting Exelon Corporation (NYSE: EXC) to have earned $0.68 per share on revenue of $7.52 billion in the latest quarter. Exelon shares rose 0.34 percent to close at $35.38 on Thursday.

  • [By Monica Gerson]

    Exelon Corporation (NYSE: EXC) is expected to report its quarterly earnings at $0.68 per share on revenue of $7.52 billion.

    CST Brands Inc (NYSE: CST) is projected to report its quarterly earnings at $0.22 per share on revenue of $2.30 billion.

Top 10 Medical Stocks To Invest In 2018: T2 Biosystems, Inc.(TTOO)

Advisors’ Opinion:

  • [By Lisa Levin]

    T2 Biosystems Inc (NASDAQ: TTOO) shares were also up, gaining 15 percent to $7.48 after the company disclosed a $40 million equity investment by partner Canon U.S.A.

  • [By William Romov]

    Penny Stocks to Buy for December 2017, No. 5: T2 Biosystems Inc. (Nasdaq: TTOO)

    Currently trading at $4.10 per share, T2 Biosystems Inc. (Nasdaq: TTOO) makes diagnostic products for biological in vitro research. It has the highest share price of the penny stocks on our list today.

  • [By Lisa Levin]

    Shares of T2 Biosystems Inc (NASDAQ: TTOO) were down 29 percent to $5.41. T2 Biosystems extended timeline for the completion of the T2Bacteria trial. BTIG downgraded the rating on T2 Biosystems from Buy to Sell, while lowering the price target from $12 to $4.

Hot Blue Chip Stocks For 2018

I will get right to it. After describing the reasons behind its meteoric rise and the discussing why this name was one of my top blue chip top picks for 2017, it comes down to performance. Just this morning Bank of America (NYSE:BAC), as well as other large banks, are out with key earnings reports. This matters for the 2017 call and it matters for the share price which has skyrocketed in the last few months. It’s about the performance. Performance not just on the top and bottom lines but also in several key metrics that I follow closely for all major banks. The bank has come a long way from it facing extinction, and it took we the people to keep it alive. Today Bank of America is one of the largest banks in the United States by assets and yes, it has recovered from the Great Recession. Is it firing on all cylinders like it was pre-recession? No, unfortunately it is not, but it is getting there. Can you stick with the name? We need to examine the company’s most recent earnings and key metrics to make that determination.

Hot Blue Chip Stocks For 2018: East West Bancorp Inc.(EWBC)

Advisors’ Opinion:

  • [By Ben Levisohn]

    The twenty stocks in Worth’s basket are: Ameriprise Financial (AMP) Bank of America, Banner (BANR), Citigroup, Citizens Financial Group (CFG), East West Bancorp (EWBC), First NBC Bank Holding (FNBC), HFF (HF), KeyCorp(KEY), Legacy Texas Financial Group (LTXB), Lincoln National (LNC), Morgan Stanley, Old National Bancorp (ONB), PacWest Bancorp (PACW), PNC Financial Services Group (PNC), Principal Financial Group (PFG), Stifel Financial (SF), SVB Financial Group (SIVB), TCF Financial (TCB), and Wells Fargo.

Hot Blue Chip Stocks For 2018: Discovery Communications, Inc.(DISCA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

    Analysts are expecting Discovery Communications Inc. (NASDAQ: DISCA) to have earned $0.47 per share on revenue of $1.69 billion in the latest quarter. Discovery Communications shares rose 0.17 percent to $29.08 in after-hours trading.
    Analysts expect T-Mobile US Inc (NASDAQ: TMUS) to report

  • [By Lisa Levin]

    Discovery Communications Inc. (NASDAQ: DISCA) announced plans to acquire Scripps Networks Interactive, Inc. (NYSE: SNI) for $14.6 billion.

    Discovery will pay $90 per share in cash and stock to buy Scripps. The transaction is projected to close by early 2018.

Hot Blue Chip Stocks For 2018: Cognizant Technology Solutions Corporation(CTSH)

Advisors’ Opinion:

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Thursday's regular session.

  • [By Lee Jackson]

    Cognizant Technology Solutions Corp. (NASDAQ: CTSH) is starting to show up as a stock to buy for many of the Wall Street firms we cover. The company was very bullish at the conference and cited a very solid demand environment that is expected to continue through next year. The Deutsche Bank target for the stock is placed at $92, while the consensus number is at $87.

  • [By Keith Speights]

    That’s a pretty good definition of leadership, but it’s not an easy one to accomplish. However, the CEOs of Celgene (NASDAQ:CELG), Cognizant Technology Solutions (NASDAQ:CTSH), General Electric (NYSE:GE), MasterCard (NYSE:MA), and Texas Instruments (NASDAQ:TXN) have been able to achieve this translation very well.

  • [By Shanthi Rexaline]

    The industry — valued at over $150 billion and comprising companies such as Wipro Limited (ADR) (NYSE: WIT), Cognizant Technology Solutions Corp (NASDAQ: CTSH), Infosys Ltd ADR (NYSE: INFY) and Tata Consultancy Services — has thus far been competing effectively on certain unique selling propositions such as low-cost technology skills and high quality manpower.

  • [By Monica Gerson]

    Analysts expect Cognizant Technology Solutions Corp (NASDAQ: CTSH) to report its quarterly earnings at $0.79 per share on revenue of $3.23 billion. Cognizant Technology shares gained 1.75 percent to $58.60 in after-hours trading.

  • [By Lisa Levin]

    Cognizant Technology Solutions Corp (NASDAQ: CTSH) reported better-than-expected earnings for its first quarter, but issued a weak guidance for the current quarter.

Hot Blue Chip Stocks For 2018: GigaMedia Limited(GIGM)

Advisors’ Opinion:

  • [By Jim Robertson]

    Today, our Under the Radar Moversnewsletter suggested small cap online gaming and cloud computing GigaMedia Limited (NASDAQ: GIGM) as a bullish long trade:

Best High Tech Stocks To Watch Right Now

Piper Jaffray’s Joshua Schimmer and team offer their take on the Biogen (BIIB) takeover speculation that sent shares of the biotech giant soaring this afternoon:

Bloomberg News/Scott Eisen

Biogenshares are trading higher on a WSJ report which indicates the company may have interest from prospective pharma buyers. The WSJ is one of the more credible sources for such speculation and is often a publication used to put companies ‘in play’, we believe. Because of its higher bar for sourcing M&A interest such as this, we think the report is a strategy being used to catalyze a potential deal. That said, we believe there are a number of challenges to be overcome for any transaction to materialize. As we have noted recently our outlook on BIIB is more optimistic, and there is now a new dynamic to the investment opportunity…

Best High Tech Stocks To Watch Right Now: GigaMedia Limited(GIGM)

Advisors’ Opinion:

  • [By Jim Robertson]

    Today, our Under the Radar Moversnewsletter suggested small cap online gaming and cloud computing GigaMedia Limited (NASDAQ: GIGM) as a bullish long trade:

Best High Tech Stocks To Watch Right Now: IPG Photonics Corporation(IPGP)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Monday began on a down note for the stock market, as the Dow Jones Industrials fell back down below the 20,000 level. Major market benchmarks finished with losses of 0.6% to 0.8%, and some market commentators attributed the declines to nervousness about the Trump administration’s actions to clamp down on immigration. Others noted that the latest reading of U.S. economic growth showed a 1.9% rise in gross domestic product for the fourth quarter, finishing the year with an overall GDP increase of just 1.6%, down a full percentage point from 2015’s growth. Despite the overall sullen mood in the market, some stocks gained ground, and GoPro (NASDAQ:GPRO), Movado Group (NYSE:MOV), and IPG Photonics (NASDAQ:IPGP) were among the best performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.

Best High Tech Stocks To Watch Right Now: Catalent, Inc.(CTLT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Catalent Inc (NASDAQ: CTLT) shares were also up, gaining 15 percent to $40.57 as the company reported stronger-than-expected results for its fourth quarter on Monday.

Best High Tech Stocks To Watch Right Now: Frontier Communications Corporation(FTR)

Advisors’ Opinion:

  • [By Paul Ausick]

    Frontier Communications Corp. (NASDAQ: FTR) dropped about 4.2% on Wednesday to record a new 52-week low of $2.51 against a high of $5.75. The stock closed at $2.62 on Tuesday. Volume was about a third higher than the daily average of around 25 million shares. The company had no specific news Wednesday, but the struggling company continues getting slaughtered.

  • [By Daniel B. Kline]

    Frontier Communications (NASDAQ:FTR) faces a key moment when it reports fourth-quarter results Feb. 27.

    The company has already reported on two quarters since it spent $10.45 billion buying Verizon’s (NYSE:VZ) wireline operations in California, Texas and Florida (CTF). That was a risky deal that gave the company 3.3 million new voice connections, 2.1 million more broadband subscribers, and 1.2 million FiOS video customers.

  • [By Brian Stoffel]

    The past few days have been utterly painful for shareholders of Frontier Communications (NASDAQ:FTR). After analysts called the company’s dividend into question, shares have fallen sharply — and they have lost almost half of their value since just this January.

  • [By Adam Levy]

    Frontier Communications (NASDAQ:FTR) has been shedding both pay-TV and broadband internet customers over the past year, growing solely through acquisitions it can’t really afford. The company acquired some of Verizon’s (NYSE:VZ) FiOS property earlier this year for $10.3 billion, and it’s managed to already lose a good chunk of what it paid for.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Tuesday was Frontier Communications Corp. (NASDAQ: FTR) which traded down 7% at $13.88. The stocks 52-week range is $1.03 to $14.70. Volume was over 6.1 million versus the daily average of 37.5 million shares.

  • [By Ben Levisohn]

    Frontier Communications (FTR) sunk to the bottom of the S&P 500 today.

    Getty Images

    Frontier Communicationsdropped 4.7% to $2.41, while the S&P 500 declined 0.3% to 2,365.45.

    Why did Frontier sink today? There’s no news that I’ve been able to find, so let’s blame the Federal Reserve, which is widely expected to hike interest rates tomorrow. Frontier is primarily known for paying a hefty dividend–it now tops 17%–and dividends tend to fall out of favor when interest rates rise. (Utilities, however, dropped just 0.1% today, so maybe that theory is bunk.)

    Frontier Communications was the biggest loser last week when it dropped 5.1% after getting cut toNeutral from Buy at BofA Merrill Lynch. It was a string of events that began with Frontier’s earnings on Feb. 28, earnings that led Wells Fargo to opine that the company was still a “show me story.”

    Frontier Communications’ market capitalization fell to $2.8 billion today from $3 billion yesterday. It reported a net lossof $376 million on sales of $8.9 billion in 2016.

best stock trading software

Helios and Matheson (NASDAQ:HMNY) acquired the RedZone Map app last summer. I just got back from the trip of a lifetime to Hawaii and found this Helios and Matheson app extremely useful.

The story of how I discovered the app is a little embarrassing; it relates to a guilty pleasure of mine. I have always loved watching the reality show “Dog the Bounty Hunter,” not exactly the most intellectually stimulating of programs.

Image Source: 1075koolfm.com

If you aren’t familiar with the show it follows a bounty hunter named Duane “Dog” Chapman who travels the rough areas of the Oahu tracking fugitives. By watching that show I saw parts of Hawaii I did not want my family to see.

Before taking our trip to Hawaii I researched ways I could navigate our rental van around the island without ending up in dangerous places. That is how I discovered Helios and Matheson’s RedZone Map app.

best stock trading software: bebe stores, inc.(BEBE)

Advisors’ Opinion:

  • [By Lisa Levin]

    bebe stores, inc. (NASDAQ: BEBE) shares dropped 26 percent to $3.86. bebe stores will reportedly license www.bebe.com domain name, social media accts. and international wholesale agreements to one or more third parties, according to Reuters.

  • [By WWW.THESTREET.COM]

    Not helping matters was a continued drumbeat of retail death stories such as Payless possibly closing 500 stores, Bebe (BEBE) on the verge of shuttering 170 stores and Sears Holdings’  (SHLD) CFO spreading #fakenews in a new blog post that the retailer is a “viable” entity. It’s not, especially after the language it slipped in its new annual report on Tuesday. 

  • [By Lisa Levin] Related HTGM 20 Biggest Mid-Day Losers For Thursday 25 Stocks Moving In Thursday's Pre-Market Session HTG Molecular Diagnostics Obtains CE Mark for its HTG EdgeSeq ALKPlus Assay EU (GuruFocus)
    Related SSH 15 Biggest Mid-Day Gainers For Wednesday 12 Biggest Mid-Day Losers For Tuesday Healthcare – Top 5 Gainers / Losers as of 11:00 am (Seeking Alpha) Gainers
    HTG Molecular Diagnostics Inc (NASDAQ: HTGM) rose 63.6 percent to $3.50 in pre-market trading after the company disclosed that it has obtained CE marking in the EU for HTG EdgeSeq ALKPlus Assay.
    Sunshine Heart Inc (NASDAQ: SSH) rose 20.3 percent to $2.61 in pre-market trading after the company issued a business update regarding execution of its strategic growth plan.
    bebe stores, inc. (NASDAQ: BEBE) shares rose 11.1 percent to $4.29 in pre-market trading after the company disclosed that it is exploring strategic alternatives.
    Cancer Genetics Inc (NASDAQ: CGIX) rose 10.3 percent to $3.20 in pre-market trading after the company posted a narrower-than-expected quarterly loss.
    Five Below Inc (NASDAQ: FIVE) rose 8.8 percent to $41.50 in pre-market trading after the company reported better-than-expected earnings for its fourth quarter.
    FireEye Inc (NASDAQ: FEYE) rose 8 percent to $12.40 in pre-market trading. Goldman Sachs upgraded FireEye from Sell to Buy.
    PVH Corp (NYSE: PVH) shares rose 7.4 percent to $97.60 in pre-market trading after the company posted upbeat earnings for its fourth quarter and issued a strong earnings forecast.
    Bitauto Hldg Ltd (ADR) (NASDAQ: BITA) shares rose 7 percent to $26.00 in pre-market trading after dropping 1.30 percent on Wednesday.
    Pingtan Marine Enterprise Ltd (NASDAQ: PME) rose 6.6 percent to $4.50 in pre-market trading after gaining 0.48 pe
  • [By WWW.THESTREET.COM]

    Just in the past few weeks, Wall Street has seen bankruptcy filings from sporting goods retailer Gander Mountain, RadioShack successor General Wireless Operations, everyday value price department store operator Gordmans Stores (GMAN) and appliances, electronics and furniture retailer HHGregg (HGG) . Last Wednesday, children’s apparel retailer Gymboree cautioned it was running low on cash and may not survive. Sears Holdings Corp. (SHLD) voiced concerns on Tuesday about its ability to stay in business, while women’s apparel chain Bebe (BEBE) is reportedly on the brink of closing all 170 of its stores.

best stock trading software: Panasonic Corporation (PCRFY)

Advisors’ Opinion:

  • [By Ben Levisohn]

    During the early stages of a new innovation, interdependent architectures and integrated companies best optimize performance and functionality. This trend has played out in computing and handsets, and we see the same trend playing out in EVs. We find Tesla and BYD1 , by far, the most vertically integrated players in EVs, with huge scale advantages. In addition, LG Chem, Panasonic (PCRFY), Samsung SDI, BYD, and CATL are clear scale leaders in batteries (CATL is not publicly traded. All but Samsung SDI and BYD are not covered by Bernstein.).

  • [By SEEKINGALPHA.COM]

    Clean Technica reported on September 1 that “Sony is entering the EV battery manufacturing industry”. And “considering that electric vehicle batteries are going to be the main supply bottleneck for the upcoming auto market’s embrace of EVs, the entry of Sony into the field is very notable. Most of the other manufacturers (Panasonic (OTCPK:PCRFY), LG Chem (OTC:LGCLF), etc.) already have more or less all of their production capacity locked up for the coming years – meaning there’s not much left for the auto manufacturers that are running behind, thereby limiting potential EV sales for the firms in question. Sony’s (NYSE:SNE) entry into the field should open things up a bit more”. Certainly a good move by Sony and helpful for the EV companies that will find themselves in need of batteries, and limited availability, should EVs reach 10% by 2020.

  • [By SEEKINGALPHA.COM]

    A Unilever vs. Panasonic (OTCPK:PCRFY) showdown seems to be something out of an alternative, weird universe. But that’s exactly what has been happening in the Asia-Pacific region, where Unilever is now a major seller of air and water purification devices. The acquisitions of Qinyuan and Pureit water purifiers, as well as the acquisition of Sweden-based Blueair in 2016, reflects Unilever’s latest growth strategy of reducing exposure to low-growth brands in favor of greater investments in higher-growth products with strong social and environmental credentials.

best stock trading software: GigaMedia Limited(GIGM)

Advisors’ Opinion:

  • [By Jim Robertson]

    Today, our Under the Radar Moversnewsletter suggested small cap online gaming and cloud computing GigaMedia Limited (NASDAQ: GIGM) as a bullish long trade:

best stock trading software: Mallinckrodt plc(MNK)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Mallinckrodt (MNK) tumbled to the bottom of the S&P 500 today as weakness that began last month even before its fourth-quarter earnings continued into year end.

    Agence France-Presse/Getty Images

    Mallinckrodtdropped 2.7% to $51.77 today, while the S&P 500 rose 0.2% to 2,268.88.

    Mallinckrodt was the biggest loser in the S&P 500 for two consecutive days in mid-November, and again after reporting its earnings.

    Mallinckrodt’s market capitalization fell to $5.5 billion today from $5.6 billion yesterday. It reported net income of $489 million on sales of $3.38 billion in fiscal 2016.

    Mallinckrodt has dropped 31% so far this year.

  • [By Ben Levisohn]

    Mallinckrodt (MNK) tumbled to the bottom of the S&P 500 today after Citron Research accused the company of fraud.

    Getty Images

    Mallinckrodt tumbled 12% to $59.60 today, while the S&P 500 declined 0.2% to 2,176.94.

    Leerink’s Jason Gerberry and Etzer Darout explain the allegations:

    Mallinckrodtshares are down -7-8% based on a short report citing CMS dashboard data which call into question Acthar Gel sales derived from government sources (CMS; Medicaid & Medicare). The report appears to overstate Acthar CMS sales as a percent of total product sales, as the methodology utilized by CMS drug spending dashboard for Medicare spend is based on gross sales, not net., although it’s unclear to what extent Acthar CMS sales are overstated.

    The report suggestsMallinckrodt mgmt understated combined Medicaid/Medicare sales on an investor call, saying it was about a little bit higher than a quarter of the business vs. gross sales on CMS dashboard implying sales were 61% of total Acthar net revenue (an apples to oranges comparison). We dont know the exact net sales of Acthar to Medicare/Medicaid, but we believe it is safe to assume Medicaid, after CPI price penalties had high discounts/rebates and assuming an 80% gross-to-net ratio on the Medicare book ($504m gross) suggests Acthar net sales would be closer to 38-45% range vs. the 61% figure cited in the short-report. Why this may matter Acthar Gel is an old product lacking good randomized, controlled data consistent with most products approved in the modern era. The report appears to be an attempt to call into question whether the government should be paying Acthars average $80-100k net price/patient/year by calling to this to the attention of government figures who have been targeting excessive drug pricing issues. This type of issue became a major headache for Mylan (MYL) investors recently with EpiPen.Mallinckrodt is presenting at a compe

  • [By Johanna Bennett]

    Sell-side analysts continue to defend drug maker Mallinckrodts (MNK) shares on the heel of Citron Researchs report on the company released last week.

    Earlier today, UBS analyst Marc Goodman and his team weighed into the fray, proclaiming that a misunderstood situation creates opportunity.

    Goodman, who rates Mallinckrodt at a buy with a $92 price target, argues that Mallinckrodt is a different breed from other specialty drug makers, with high-quality earnings, sales growth fueled by volume not price hikes and an emerging pipeline we think is not just underappreciated but really not even part of the conversation with most investors.

    Also, he argues that Mallinckrodt continues to be misunderstood by investors.

    Goodman goes into goes into more detail:

    we were surprised this past week by the debate around Acthar’s Medicare exposure (~30% or ~40%), which in our view has little relevance to the overall MNK story. The key debate since the Questcor deal has been Acthar payer coverage and concerns for more barriers andor coverage blocks by the payers. There was reason for concern just 2 years ago, in our view, as several important payers increased barriers. But mgt’s aggressive focus on enhancing clinical and health-economics data to help support better coverage seems to be working and has resulted in improved coverage, which we believe is still not well appreciated.

    Mallinckrodt shares continue to climb today, rising 4.8% to a recent $57.20.

  • [By Keith Speights]

    Although 2016 wasn’t exactly the greatest year for healthcare stocks in general, there really aren’t very many true bargains to be found in the industry. However, three healthcare stocks do appear to be priced well below what they’re worth. Here’s why Gilead Sciences (NASDAQ:GILD), Lantheus Holdings (NASDAQ:LNTH), and Mallinckrodt (NYSE:MNK) look to be ridiculously cheap right now.

  • [By Ben Levisohn]

    Mallinckrodt (MNK) tumbled to the bottom of the S&P 500 today after its earnings topped the Street consensus but offered commentary that spooked investors.

    Agence France-Presse/Getty Images

    Shares of Mallinckrodt dropped 9.1% to $52.42, while the S&P 500 rose 0.1%.

    Barclays analyst Douglas Tsao and Morgan Williams callMallinckrodt’s plunge “outsized.” They explain why:

    In our view the sell-off afterMallinckrodt reported CY3Q16 earnings is outsized considering much of the disclosure on the call was largely expected, including specialty generics weakness and the 2017 outlook, which seemed relatively mild. While outsized Acthar contribution to EBITDA may be accounting for some of the sell-off, wed argue that there is benefit to the brand outperforming, especially considering the need to offset Therakos production issues in CY4Q16 and CY1Q17 as well as specialty generics weakness. We recognize some lingering headline risk associated with media reports criticizing the cost of Acthar to Medicare, after CMS released its prescription drug spending dashboard.

    Mallinckrodt’s market capitalization fell to $5.7 billion today from $6.2 billion yesterday. It reported net income of $306 million on revenue of $3.3 billion in 2015.

    This marks the third time in less than two weeks that Mallinckrodt was the S&P 500′s biggest loser.

  • [By Keith Speights]

    That’s the question investors are trying to answer about how President Trump’s policies might impact healthcare stocks. So far, specific policy proposals put forward by the president appear likely to cause significant problems for certain healthcare stocks. Here’s why three of President Trump’s policies could be downright terrible for Molina Healthcare(NYSE:MOH), Mallinckrodt (NYSE:MNK), and Illumina (NASDAQ:ILMN).

penney stocks

Chicago, IL, based Investment company RMB Capital Management, LLC buys iShares Russell 3000, Apple, STERIS PLC, Macquarie Infrastructure, Guaranty Bancorp, Sun Bancorp, Twenty-First Century Fox, LiLAC Group, Central Garden & Pet Co, Ford Motor Co, sells West Pharmaceutical Services, United Rentals, Macy’s, Ameris Bancorp, OceanFirst Financial during the 3-months ended 2016-12-31, according to the most recent filings of the investment company, RMB Capital Management, LLC. As of 2016-12-31, RMB Capital Management, LLC owns 439 stocks with a total value of $1.8 billion. These are the details of the buys and sells.

New Purchases: STE, MIC, GBNK, FOX, LILAK, F, BACPRL, IBB, EWY, MCD, Added Positions: IWV, AAPL, SNBC, CENTA, XOM, VBTX, JPM, CUK, EQBK, OPB, Reduced Positions: URI, M, CWST, FBK, AMZN, AAP, RIO, RDS.A, HTBI, BNCN, Sold Out: WST, ABCB, OCFC, ORRF, YDKN, IFN, UA, ZG, HOMB, CARO,

For the details of RMB Capital Management, LLC’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=RMB+Capital+Management%2C+LLC

penney stocks: (SIOLF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    China Life (NYSE:LFC) holds a 44 percent stake in China Guangfa Bank and a 30 percent stake in Sino-Ocean Group (OTCPK:SIOLF). Foresea owns large stakes in Gree Electric Appliances and China Vanke. If they are forced to sell their stakes, the Chinese stock market could see a sudden downturn.

penney stocks: Vascular Biogenics Ltd.(VBLT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Vascular Biogenics Ltd (NASDAQ: VBLT) were down 20 percent to $7.22. VBL Therapeutics reported pricing of 2.5 million share common stock offering for $18.75 million.

  • [By Lisa Levin]

    Shares of Vascular Biogenics Ltd (NASDAQ: VBLT) were down 17 percent to $7.43. VBL Therapeutics reported pricing of 2.5 million share common stock offering for $18.75 million.

penney stocks: Sapiens International Corporation N.V.(SPNS)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday.
    Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter.
    Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday.
    Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday.
    Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances.
    Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral.
    Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday.
    Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems.
    Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend.
    BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc.
    Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday.
    Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than

penney stocks: NQ Mobile Inc.(NQ)

Advisors’ Opinion:

  • [By Lisa Levin]

    NQ Mobile Inc (ADR) (NYSE: NQ) shares dropped 16 percent to $3.88 after the company issued an update on the FL Mobile divestment. NQ Mobile is expected to report Q4 financial results on March 21, 2016.

  • [By Belinda Cao]

    Oberweis China Opportunities Fund (OBCHX), the best-performing U.S.-based fund investing in Chinese stocks, said Internet companies from NQ Mobile Inc. (NQ) to Qihoo 360 Technology Co. (QIHU) will extend a rally after jumping more than three-fold this year.

  • [By Lisa Levin]

    On Thursday, telecommunications services shares gained by 0.42 percent. Meanwhile, top gainers in the sector included 8×8, Inc. (NASDAQ: EGHT), up 4 percent, and NQ Mobile Inc (ADR) (NYSE: NQ), up 2 percent.

penney stocks: GigaMedia Limited(GIGM)

Advisors’ Opinion:

  • [By Jim Robertson]

    Today, our Under the Radar Moversnewsletter suggested small cap online gaming and cloud computing GigaMedia Limited (NASDAQ: GIGM) as a bullish long trade:

penney stocks: NVIDIA Corporation(NVDA)

Advisors’ Opinion:

  • [By Virendra Singh Chauhan]

    Shares of Santa Clara, California-based NVIDIA Corporation (NSDQ:NVDA) have rallied strongly through 2016, gaining 192% in the year-to-date. And if analyst upgrades are anything to go by, this rally is far from over. After analysts at CITI and Jefferies upgraded their NVDA price targets, the teams at Evercore ISI and Loop Capital are the latest to jump onto the bullish NVDA bandwagon. But, can NVIDIA stock sustain this rally after the monstrous returns in 2016? Do fundamentals back a bullish case going into 2017? Let’s take a closer look.

  • [By Kumar Abhishek]

    Short interest in NVIDIA Corporation (NSDQ:NVDA) stock saw a drastic fall in the latest round of reporting, indicating a decline in bearish sentiment around NVIDIA stock. This is thefirst time since theend of July that short interest in NVIDIA stock has seen any significant decline. The number of shorted shares fell by more than 23% from 71.4 million shares to 54.8 million shares, with short interest coming in at 10.8% of the float and days to cover at 2 days. Short interest has followed the stock price with the number of shorted shares shooting up from 44.44 million shares at the end of July to 71.4 million in mid-December, a rise of more than 60%.

  • [By John Ballard]

    Over the past year, NVIDIA’s (NASDAQ:NVDA) stock has rocketed to the stratosphere, up some 300%, and that means the GPU maker’s financial results are more scrutinized than ever. When NVIDIA announces fourth-quarter earnings results on Thursday, Feb. 9, investors will be looking to see if it can prove itself worthy of its rich valuation.

  • [By Arie Goren]

    Advanced Micro Devices, Inc.(NSDQ:AMD)had been by far the best performer in 2016 among all the 413 Russell 3000 tech stocks. Its stock price appreciation of 295.1% in 2016 was significantly higher than the second ranked tech stock NVIDIA Corporation (NVIDIA (NSDQ:NVDA)which gained 223.8% and the third-ranked stock Oclaro Inc. (NSDQ:OCLR)which was up 157.2% in 2016.

  • [By Sreekanth Anasa]

    Shares of Santa Clara, California-basedNVIDIA Corporation (NASDAQ:NVDA)took another tumble yesterday (April 10th), falling by more than 2.5%. NVIDIA stock tanked due to the influx of fresh bearish commentary from the investment research firmBMO Capital Markets. NVDA stock closed below $100 for the first time since the early March when it had registered its lowest close ($97.67) in 2017. NVDA stock is trading very near to its lowest close in 2017 and bears the risk of going down much lower. NVIDIA stock has not been able to hold on to its good start to the year and has lost almost 8.5% YTD. We did suggest recently NVDA stock is a high-risk bet in the near term. Now the question arises, hasNVIDIA Corporation (NASDAQ: NVDA) stock bottomed out? Or, there is still more downside left for NVDA stock. Let’s take a closer look.

  • [By Lisa Levin]

    Wednesday afternoon, technology shares gained by 0.65 percent. Meanwhile, top gainers in the sector included NVIDIA Corporation (NASDAQ: NVDA), and GigPeak Inc (NYSE: GIG).